Tagrisso is approved as a combination treatment with chemotherapy to treat locally advanced or metastatic EGFR mutant non-small cell lung cancer (NSCLC), EGFR T790m-positive NSCLC, and as an ...
Pharmaceutical Technology
10 hours ago
Business Today
Union Budget 2024: AstraZeneca set to gain from customs duty exemption on key cancer drugs in full Budget
15 hours ago
Clinical Trials Arena
Enhertu set to become a blockbuster drug after outperforming Kadcyla
3 days ago
Semafor
Big Pharma pushes early detection in Africa cancer battle
14 hours ago
Hindustan Times
Drug giants eye China for deals despite growing Sino-US tensions
2 days ago
Covid-19 vaccines: serious adverse events explained
View all
British-Swedish pharmaceutical company
astrazeneca.com
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. Wikipedia
Stock price: AZN (NasdaqGS) $79.71 +0.54 (+0.68%)
Wed, Jul 24, 2024, 4:00PM EDT